Related Experiment Video
Updated: Oct 12, 2025
Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons
Published on: June 30, 2022
Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization
Stanley Du Preez1,2,3,4, Natalie Eaton-Fitch1,2,3, Helene Cabanas2,5
1National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute, Griffith University, Gold Coast 4215, Australia.
Abstract:
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisystemic disorder responsible for significant disability. Although a unifying etiology for ME/CFS is uncertain, impaired natural killer (NK) cell cytotoxicity represents a consistent and measurable feature of this disorder. Research utilizing patient-derived NK cells has implicated dysregulated calcium (Ca2+) signaling, dysfunction of the phosphatidylinositol-4,5-bisphosphate (PIP2)-dependent cation channel, transient receptor potential melastatin (TRPM) 3, as well as altered surface expression patterns of TRPM3 and TRPM2 in the pathophysiology of ME/CFS. TRPM7 is a related channel that is modulated by PIP2 and participates in Ca2+ signaling. Though TRPM7 is expressed on NK cells, the role of TRPM7 with IL-2 and intracellular signaling mechanisms in the NK cells of ME/CFS patients is unknown. This study examined the effect of IL-2 stimulation and TRPM7 pharmacomodulation on NK cell cytotoxicity using flow cytometric assays as well as co-localization of TRPM7 with PIP2 and cortical actin using confocal microscopy in 17 ME/CFS patients and 17 age- and sex-matched healthy controls. The outcomes of this investigation are preliminary and indicate that crosstalk between IL-2 and TRMP7 exists. A larger sample size to confirm these findings and characterization of TRPM7 in ME/CFS using other experimental modalities are warranted.
Insights
Natural killer (NK) cell function is impaired in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This study suggests a link between IL-2 and TRPM7 in ME/CFS NK cells, warranting further investigation.
Area of Science:
- Immunology
- Cellular Biology
- Neuroscience
Background:
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder with significant disability.
- Impaired natural killer (NK) cell cytotoxicity is a consistent feature of ME/CFS.
- Previous research points to dysregulated calcium signaling and TRPM channel dysfunction in ME/CFS pathophysiology.
Purpose of the Study:
- To investigate the role of TRPM7 in NK cells of ME/CFS patients.
- To examine the effect of IL-2 stimulation and TRPM7 pharmacomodulation on NK cell cytotoxicity.
- To explore the co-localization of TRPM7 with PIP2 and cortical actin in ME/CFS NK cells.
Main Methods:
- Utilized flow cytometry to assess NK cell cytotoxicity.
- Employed confocal microscopy for co-localization studies.
- Studied 17 ME/CFS patients and 17 healthy controls.
Main Results:
- Preliminary findings indicate a crosstalk between IL-2 and TRPM7 in NK cells.
- Observed alterations in TRPM7 and its interactions within NK cells of ME/CFS patients.
Conclusions:
- The study provides preliminary evidence for a connection between IL-2 and TRPM7 in ME/CFS.
- Further research with larger sample sizes and diverse experimental approaches is needed to confirm these findings and fully characterize TRPM7's role in ME/CFS.
